Picture of Prostatype Genomics AB logo

PROGEN Prostatype Genomics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Prostatype Expects Significantly Better Performance In Q3

Aug 17 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * Q3 WILL PERFORM SIGNIFICANTLY BETTER AND BE MORE IN LINE
WITH
SALES GROWTH WE HAVE SEEN OVER PAST YEAR
    * TREND IN SALES GROWTH REMAINS POSITIVE

Source text for Eikon:  ID:nWkr3dhYYY 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Prostatype Genomics AB

See all news